Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
A phase 1 trial of Capecitabine and Doxifluridine in Hepatocellular carcinoma and Metastatic cancer, run by Northwestern University, completed.
Overview
Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases is a phase 1 interventional study registered as NCT00858429 by Northwestern University, with 18 participants recorded, started 2009-04-01 and reaching its primary completion in 2014-03-19. Interventions recorded: capecitabine, yttrium Y 90 glass microspheres. Conditions recorded: Liver Cancer, Metastatic Cancer.
Linked to the drug Doxifluridine because the registry names it among its interventions and Hepatocellular carcinoma and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialA Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer
Shares Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03)
Shares Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
Shares Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy
Shares Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialStudy of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
Shares Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPhase I-II Clinical Trial of Utidelone Capsule in Patients With Advanced Solid Tumors
Shares Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of DB-1310 in Advanced/Metastatic Solid Tumors
Shares Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.